I am a Certified Gerson Practitioner, and a Registered RGCC Practitioner. I specialize in providing and coordinating holistic integrative nutritional oncology therapy guidance via Telehealth.
Therapies are integrated with application of scientific data from RGCC (Research Genetic Cancer Centre) testing that enables personal customization of case management to achieve maximal positive clinical outcomes
Dr. Miven Donato graduated from Palmer College of Chiropractic in Davenport, Iowa (2001) with a Doctor of Chiropractic (DC) degree. He also has a Doctor of Physical Therapy (DPT) degree from Creighton University in Omaha, Nebraska (2009). His undergraduate degrees include a BSc in Physical Therapy from Loma Linda University (1990) and BSc in Medical Technology/Clinical Laboratory Science from Union College/Florida Hospital (1987). His solo practice in 2001 started with emphasis in orthopedic and sports therapy including dietary, health fitness and lifestyle medicine.
In 2010, Dr. Donato began to focus his practice in nutritional therapy. In 2012, he completed certification as a Gerson Practitioner at the Gerson Institute. Soon after he became an instructor for the Gerson Practitioner Training Program and was instrumental in starting the new distance-based online program in 2015. By 2018, he narrowed his scope of professional specialization to holistic integrative nutritional oncology care.
2018 was also the year Dr. Donato was introduced by a professional colleague to RGCC (Research Genetic Cancer Centre) testing. The blood test, also known as the "Greece Test" is a "liquid biopsy" that includes circulating tumor cell (CTC) detection, identification of phenotype biomarkers, chemosensitivity testing of cytotoxic agents and natural substances to cancer cells in peripheral blood circulation that provides scientific data for clinical personalization of cancer therapy.
Dr. Donato's experience in successful application of the RGCC data in clinical practice was pivotal to being invited by RGCC International to join the staff of clinical/technical advisers in January 2022. Dr. Donato assumed his part-time professional duty with RGCC International North America as a Clinical Consultant & Trainer. He also serves as a live trainer for oncology tests and interpretation at RGCC College, an online training program for new physicians coming onboard to become credentialed RGCC practitioners.
To date, Dr. Donato has managed several thousand client cases in over 200 countries via Telehealth. He believes that the layered application of principles from science in molecular oncology within an integrative therapeutic framework over a platform of whole foods plant-based diet and lifestyle medicine leads to higher positive clinical outcomes in cancer therapy.
Dr. Donato takes the role of a client health advocate providing informed choices in healthcare. The client as a team member makes the final decision to follow a health path based on informed choices. Dr. Donato helps to coordinate and integrate the client's choice and interfaces therapy tasks from various healthcare providers into one integrative cancer therapy protocol.
To attain a level of consciousness that a healthy mind, body, and spirit is a balance that leads to a satisfying, happy, and joyful life, which is divinely inspired.
To reach the maximum positive clinical outcomes in therapy while maintaining an etiquette of practice that serves to satisfy societal expectations.
This is a live online video meeting consultation with Dr. Donato who will answer general questions regarding Gerson Therapy, RGCC testing, and distance-based case management services. Click Here to book the 30-minute appointment
This appointment will help determine if you are a good candidate for onboarding case management with Dr. Donato.
This is a live online video meeting consultation with Dr. Donato to assist you in selecting and ordering RGCC testing. There are many types of RGCC tests available. Dr. Donato will explain the purpose of each test so you can choose the right one for your health condition. Click Here to book the 30-minute appointment.
This is a live online video meeting consultation with Dr. Donato to go onboard case management. Current clinical signs, symptoms, and health status will be reviewed along with blood labs, imaging, and pathology report. Discussion will include therapy strategies, expectations, and nutritional metabolic therapy protocol. Dr. Donato will explain how the therapy protocol works. Click Here to book the 1 hour appointment.
If you have significant functional impairment and are not sure you are a good candidate to go onboard case management, please select the above Question & Answer Session appointment first. You can also Click Here.
After you book the New Client Initial Consult, follow the 5 Steps to Come Onboard as a Client for Case Management below.
This is a live online video meeting consultation with Dr. Donato for RGCC Test Analysis, Detailed Interpretation and Explanation with commentary on PAST or CURRENT test results. This service is intended for those who do not fully understand the test results and how the results are applied.
Click the specific RGCC test interpretation to book a consultation:
OncoTrace or OncoTrail Test ONLY: Click Here
Onconomics Plus Test ONLY: Click Here
OncoTrace or OncoTrail + Onconomics Plus Tests: Click Here
Download and complete the 2 sets of fill-in forms below and send to DrDonato@pm.me using a secure and encrypted email account. If you don't have a secure and encrypted email account, see Step 5 below.
You can provide the document after the meeting if it is not yet accessible
If you do not have current lab test results (less than 4 weeks) for the baseline and need to order blood tests, follow the instructions below on "Ordering Your Own Baseline Blood Tests" or if you wish for your healthcare insurance to cover this you can request your medical doctor to order the baseline lab tests listed.
Radiology reports from PET/CT, CT, MRI, NM Whole Body Bone Scan, Ultrasound, Mammogram, or plain x-rays, if any.
Use your secure and encrypted email account for all correspondence and email attachments between you and Dr. Donato for secure end-to-end encryption.
Comprehensive Wellness Profile (CWP): This bundled test consists of CBC with differential, Glucose, Electrolytes, Lipid Panel, Liver Panel, TSH, Kidney (metabolic panel), Mineral and Bone.
Inflammation Markers: CRP high sensitivity, ESR (sed rate), and Ferritin.
Vitamins: Vitamin B2 serum, Vitamin D 25 Hydroxy
Urinalysis, Complete with Microscopic Examination
Cancer Marker (below is a list of general cancer markers for biopsy-proven or established diagnosis of cancer ONLY and NOT for screening):
CA 27.29 or CA 15-3 (for Breast Cancer)
PSA (for Prostate Cancer)
CEA (for Colon Cancer or Lung Cancer)
CA 19-9 (for Pancreatic Cancer)
CA 125 (for Ovarian Cancer)
Thyroglobulin (for post-thyroidectomy Papillary Thyroid Cancer)
S100B (for metastatic Melanoma)
AFP (for Hepatocellular Liver Cancer)
Beta-2 Microglobulin (for Lymphoma or Leukemia)
CGA (for Neuroendocrine Cancer)
Doctors Orders Not Necessary. Dr. Donato uses DirectLabs, a large client of Quest Diagnostics that provides discounted lab testing to the public. To order the above listed baseline lab tests, Click Here
DirectLabs services not available in NJ, NY, and RI
Quest services not available in AZ
Note: When ordering the routine lab tests at checkout, you have the option of instructing DirectLabs to send the test results to Dr. Donato besides automatically receiving yours. Enter the email address DrDonato@pm.me
RGCC stands for Research Genetic Cancer Centre. It was founded by medical oncologist and genetics researcher, Dr. Ioannis Papasotiriou, MD, PhD in 2004. RGCC is an oncology research and development company that has 25+ branches in 20+ countries, and the global presence is increasing. RGCC headquarters is in Switzerland and general lab in Greece. There are other labs in Germany and India that are for research purposes.
RGCC testing is a molecular oncology blood test also known as “liquid biopsy” that detects whole cancer cells (circulating tumor cells) disseminated from primary and/or metastatic sites or from unknown primary sites at very low level, and enabling enumeration for the baseline, and for identification of the heterogeneous cancer cell population. The test is not meant to replace current conventional diagnostics, but like imaging and routine blood work it provides a more accurate assessment of the cancer status when combined with routine imaging study and routine blood labs.
An analogy comparing conventional diagnostics with RGCC testing is as follows. When doing clinical imaging studies (PET/CT, CT, MRI, US, Mammogram scans) of the body, on one hand it is like looking down at a forest from a drone high above and seeing the landscape and the borders or perimeters of an area of interest but unaware of what is happening at the ground level under the canopy of the trees. RGCC testing on the other hand is like looking from the roots of the trees up to the ground level to see what is happening. The view from the drone can spot changes in the topography, shape, borders, and perimeters of the forest indicating suspicious activity below, but a closer look down at the ground level and roots of the trees may reveal a different situation. Combining the two information produces an accurate assessment of the area of interest for baseline and future comparisons.
When making clinical decisions and creating therapy plans, an assessment or clinical impression of the disease condition needs to be as accurate as possible. Conventional oncology diagnostics have relied on technologies that have not matched the growing molecular oncology diagnostics until recent years. Around 2015, advances in molecular oncology diagnostics introduced “liquid biopsy”, which involves whole blood studies of circulating tumor DNA (ctDNA) from circulating tumor cells (CTC). Detecting ctDNA enables early cancer diagnosis for conventional oncology. The process of determining specific treatment plan is based on the biopsy-proven cancer diagnosis and what the FDA has approved for treatment of that diagnosis.
Unlike detecting ctDNA, RGCC testing detects the circulating tumor cells in the blood and includes chemosensitivity testing that determines what is or what are the most effective therapeutic anti-cancer agents (drugs or natural supplements) against the cancer cells in-vitro. So, rather than creating a specific treatment plan based on biopsy-proven diagnosis, RGCC testing enables creation of personalized integrative therapy plan based on the individual's cancer cell physiology. There is no need to guess what works when using RGCC testing. The testing also provides the information on CTC resistance to treatment factors and tumor related gene expression rates (mutated genes that support cancer proliferation) for further customization of personalize therapy. Currently 171 anti-cancer agents are tested routinely, and additional agents can be added to the blood sample for chemosensitivity testing at the discretion of the practitioner.
Integrating RGCC testing data with conventional oncology and holistic therapy enables maximum potential for positive clinical outcomes in oncology care.
During the RGCC Test Order Consult Dr. Donato will initiate a request to RGCC North America distribution center in Atlanta, GA to drop ship a RGCC test kit to your home address (for North America residents only) via FedEx Ground. Delivery takes 4-8 days depending on location. The test kit contains a disposable blood draw kit, a vial containing EDTA to collect the blood sample, collection and shipping instructions and international paperwork (mostly pre-filled except your name, signature and date of blood draw), and a pre-paid FedEx International Priority shipping label. Blood draw service is either through AnyLabTestNow center (if available in your area) or via local mobile phlebotomy service. The test kit with the collected blood sample is taken to a local FedEx Store or hub to ship. Turn around time for test results averages 14-16 days. Results will be forwarded to you by Dr. Donato.
The Gerson Therapy is a nutritional metabolic therapy started by Dr. Max Gerson, MD in the 1920s, initially as a treatment for migraines. Later the Gerson Therapy started to be used for other chronic diseases like tuberculosis. It became famous world-wide as an anti-cancer therapy. It does not cure cancer but enables the human body to heal chronic degenerative diseases including cancer over time by changes in the internal body microenvironment through diet and lifestyle changes. For very advanced diseases, the therapy may need to be integrated with other healing methods including conventional treatments.
It is important to note that the FDA has never approved the Gerson Therapy as a cancer treatment. The traditional conventional healthcare does not support this form of therapy for any sick person. However, the Gerson Therapy has been around a very long time and there are many testimonials of diseases that were healed. The therapy is not recommended for everyone and anyone who wants to do the Gerson Therapy should do extensive reading and research to increase understanding of the therapy, indications, and contraindications.
The Gerson Therapy is a home-based program that utilizes a strict plant-based diet for a period, and that includes fresh vegetable juices that is pesticide-free and organically grown as a fundamental platform to address nutritional deficiencies or malnutrition, to change the internal body environment to support reversal of chronic degenerative diseases and to support the restoration of the body systems to normal function. Among the most important body systems are the energy system and immune system.
Also fundamental in the Gerson Therapy is the elimination or purging (detoxification) of the body toxins or poisons accumulated from years of exposure to environmental toxins that hinder optimal healing and repair. The Gerson coffee enema is the gold standard in detoxification of the body.
In addition, the Gerson Therapy utilizes nutritional supplements aimed at temporarily boosting the weakened or deficient energy system, supporting the liver function, and mobilizing toxins to eliminate from the body by using a methodology of salt and water management.
You can read more about Gerson Therapy by going to Gerson.org.
Click Here to listen to an interview of Gerson Practitioners and learn what they do for their clients.
There are 3 types of positive clinical outcomes:
1. Stability of disease. This means the disease has stopped progressing. The symptoms have not worsened and is manageable. A person can live a long time at this stage with continued therapy.
2. Partial improvement. This means the disease has reduced or a malignant tumor has shrunk but did not disappear. The symptoms have improved, and body functions may have almost normalized.
3. No evidence of disease. This means the disease is no longer detected by conventional diagnostic study. There are no symptoms. Body function is normal. In essence the disease is in remission.
The services offered by Dr. Donato, LLC is not to diagnose and treat a disease. If you need a medical diagnosis and treatment, or if you have an urgent medical condition that needs medical care, please consult your primary care doctor.